1. van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407–420 (2017).
2. Cecconi, M., Evans, L., Levy, M. & Rhodes, A. Sepsis and septic shock. Lancet 392, 75–87 (2018).
3. Chousterman, B. G., Swirski, F. K. & Weber, G. F. Cytokine storm and sepsis disease pathogenesis. Semin. Immunopathol. 39, 517–528 (2017).
4. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71–109 (2011).
5. Ouyang, W. & O’Garra, A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity 50, 871–891 (2019).
6. Latifi, S. Q., O’Riordan, M. A. & Levine, A. D. Interleukin-10 controls the onset of irreversible septic shock. Infect. Immun. 70, 4441–4446 (2002).
7. Sawant, D. V. et al. Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion. Nat. Immunol. 20, 724–735 (2019).
8. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15, 277–284 (2009).
9. Wang, X., Wong, K., Ouyang, W. & Rutz, S. Targeting IL-10 family cytokines for the treatment of human diseases. Cold Spring Harb. Perspect. Biol. 11, a028548 (2019).
10. Fischer, A., Ballet, J. J. & Griscelli, C. Specific inhibition of in vitro Candida- induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J. Clin. Invest 62, 1005–1013 (1978).
11. Ashman, R. B. & Papadimitriou, J. M. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59, 646–672 (1995).
12. Fischer, A., Pichat, L., Audinot, M. & Griscelli, C. Defective handling of mannan by monocytes in patients with chronic mucocutaneous candidiasis resulting in a specific cellular unresponsiveness. Clin. Exp. Immunol. 47, 653–660 (1982).
13. Shibata, N., Suzuki, A., Kobayashi, H. & Okawa, Y. Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms. Biochem. J. 404, 365–372 (2007).
14. Shibata, N., Kobayashi, H., Okawa, Y. & Suzuki, S. Existence of novel β-1,2 linkage-containing side chain in the mannan of Candida lusitaniae, antigenically related to Candida albicans serotype A. Eur. J. Biochem. 270, 2565–2575 (2003).
15. Raschke, W. C., Kern, K. A., Antalis, C. & Ballou, C. E. Genetic control of yeast mannan structure. Isolation and characterization of mannan mutants. J. Biol. Chem. 248, 4660–4666 (1973).
16. Tang, J., Lin, G., Langdon, W. Y., Tao, L. & Zhang, J. Regulation of C-type lectin receptor-mediated antifungal immunity. Front Immunol. 9, 123 (2018).
17. Gringhuis, S. I. et al. C-type lectin DC-SIGN modulates toll-like receptor signaling via raf-1 kinase-dependent acetylation of transcription factor NF-κB. Immunity 26, 605–616 (2007).
18. Zhou, Y. et al. Oral tolerance to food-induced systemic anaphylaxis mediated by the C-type lectin SIGNR1. Nat. Med. 16, 1128–1133 (2010).
19. Saijo, S. et al. Dectin-2 recognition of α-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32, 681–691 (2010).
20. Feinberg, H. et al. Mechanism of pathogen recognition by human dectin-2. J. Biol. Chem. 292, 13402–13414 (2017).
21. Robinson, M. J. et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 206, 2037–2051 (2009).
22. Danahy, D. B. et al. Sepsis-induced state of immunoparalysis is defined by diminished CD8 T cell-mediated antitumor immunity. J. Immunol. 203, 725–735 (2019).
23. Kash, J. C. & Taubenberger, J. K. The role of viral, host, and secondary bacterial factors in influenza pathogenesis. Am. J. Pathol. 185, 1528–1536 (2015).
24. Payen, D. et al. Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series. BMC Infect. Dis. 19, 931 (2019).
25. Fong, T. A. & Mosmann, T. R. The role of IFN-γ in delayed-type hypersensitivity mediated by Th1 clones. J. Immunol. 143, 2887–2893 (1989).
26. Saeidi, A. et al. T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses. Front Immunol. 9, 2569 (2018).
27. Zhang, Y. et al. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit. Care 15, R70 (2011).
28. Venet, F. & Monneret, G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat. Rev. Nephrol. 14, 121–137 (2018).
29. Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13, 862–874 (2013).
30. Shibata, N. et al. Demonstration of the presence of α-1,6-branched side chains in the mannan of Candida stellatoidea. Eur. J. Biochem. 246, 477–485 (1997).
31. Shibata, N. et al. Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J. Biol. Chem. 270, 1113–1122 (1995).
32. Ballou, C. E., Kern, K. A. & Raschke, W. C. Genetic control of yeast mannan structure. Complementation studies and properties of mannan mutants. J. Biol. Chem. 248, 4667–4671 (1973).
33. Shibata, N. et al. Immunochemical study on the mannans of Candida albicans Nih a-207, Nih B-792, and J-1012 strains prepared by fractional precipitation with cetyltrimethylammonium bromide. Arch. Biochem. Biophysics 243, 338–348 (1985).
34. Takahara, K. et al. Difference in fine specificity to polysaccharides of Candida albicans mannoprotein between mouse SIGNR1 and human DC-SIGN. Infect. Immun. 80, 1699–1706 (2012).
35. Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. & Underhill, D. M. Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2. J. Exp. Med. 197, 1107–1117 (2003).
論文の公開元へ
